COVID-19 Pandemic

South Africa, India urge WTO to amend monopoly patent rights to ensure fair access to Covid-19 vaccines

October 6, 2020: India and South Africa have asked the World Trade Organisation on October 2, 2020, to waive some provisions in its TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement to make vaccines and treatment more accessible to low-income countries, reported Pharmalot.

Civil society groups urge G20 Finance Ministers to cancel debt and increase health care in low income countries

July 17, 2020: Finance Ministers of the world's richest countries are meeting at the G20 on July 19 to discuss how to respond to the #Covid19 pandemic. Sixty-four countries spend more on debt repayments than healthcare.

The Covid-19 crisis could mean 500 million more people are pushed into poverty. In 2020 the group of 76 poorest countries are due to spend:

European Parliament strongly backs WHO effort for equitable access to COVID-19 vaccines

July 15, 2020: In an overwhelming vote on July 10, 2020, the European Parliament supported a World Health Organization initiative to create the Technology Access Pool (C-TAP), which would collect patent rights, regulatory test data, and other information that could be shared for developing drugs, vaccines, and diagnostics to combat Covid-19 and ensure they are accessible to all..

Argentinian health groups oppose monopoly patents on remdesivir drug for coronavirus treatment

July 9, 2020: US pharmaceutical giant Gilead has filed five patent applications for a 20-year monopoly on the manufacture and commercialisation of the drug remdesivir in Argentina. Remdesivir is the first drug approved globally to treat people infected with COVID-19. If the National Institute of Industrial Property (INPI) rejects the patent, it would be a significant step toward Argentina being able to manufacture remdesivir locally at a reduced price.

Pages